Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients-Reference-Cited by-同舟云学术

Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients

Published:2022-06 Issue:6 Volume:86 Page:1236-1245
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Ao Suiting,Gao Xuemei,Zhan Jipang,Ai Lu,Li Minyi,Su Huilin,Tang Xuhua,Chu Coco,Han Jiande,Wang Fang

Funder

Guangzhou Science and Technology Program key projects

Guangdong Provincial Department of Science and Technology

National Natural Science Foundation of China

Guangzhou Municipal Science and Technology Bureau

Natural Science Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

Dermatology

Reference36 articles.

1. Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes;Struck;Intensive Care Med,2010

2. Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus;Brüggen;Br J Dermatol,2021

3. A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens–Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016;Chan;Int J Dermatol,2019

4. Association of early systemic corticosteroid therapy with mortality in patients with Stevens–Johnson syndrome or toxic epidermal necrolysis: a retrospective cohort study using a nationwide claims database;Morita;Am J Clin Dermatol,2019

5. Erythema multiforme in children. Response to treatment with systemic corticosteroids;Rasmussen;Br J Dermatol,1976

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study;Frontiers in Immunology;2024-08-07

2. A systematic review of case–control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis;Australasian Journal of Dermatology;2024-06-03

3. Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review;Current Opinion in Allergy & Clinical Immunology;2024-05-17

4. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

5. A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome;Pediatric Allergy, Immunology, and Pulmonology;2024-03-01